The global Next Generation Sequencing Market is poised for unprecedented growth, with projections estimating its value to reach an impressive $32.7 billion by 2030. This forecast represents a staggering Compound Annual Growth Rate (CAGR) of 21.7% from 2023 to 2030, underscoring the transformative impact of Next Generation Sequencing within the healthcare sector.

The Next Generation Sequencing (NGS) market is poised for exponential growth in the coming years. With advancements in technology and increasing demand for personalized medicine, NGS has become an indispensable tool in genomics research, clinical diagnostics, and drug discovery.

One of the key drivers of the NGS market is the declining cost of sequencing. The introduction of high-throughput sequencers and improved data analysis software has significantly reduced the cost per base pair, making it more accessible to researchers and clinicians. This has led to a surge in NGS applications across various fields, including cancer genomics, rare disease diagnosis, infectious disease surveillance, and agricultural genomics.

Moreover, the expanding scope of NGS beyond DNA sequencing to include RNA sequencing (RNA-Seq), whole exome sequencing (WES), and whole genome sequencing (WGS) has further fueled its adoption. These techniques enable researchers to study gene expression patterns, identify disease-causing mutations, and understand the complex interplay between genes and diseases.

Ask here for Sample Copy: https://www.snsinsider.com/sample-request/3720

Major Players Listed in the Report are as Follows:

Illumina, F. Hoffman-La Roche Ltd., QIAGEN, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, PierianDx, Genomatix GmbH, DNASTAR, Inc., Perkin Elmer, Inc., Eurofins GATC Biotech GmbH, BGI, and Others.

Next Generation Sequencing Market Segmentation as Follows:

By Product

• Consumables
  • Sample Preparation
  • Target Enrichment
  • Others
• Platforms
  • Sequencing
  • Data Analysis

 By Technology

• WGS
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
  • DNA-based
  • RNA-based

By Workflow

• Pre-Sequencing
  • NGS Library Preparation Kits
  • Semi-automated Library Preparation
  • Automated Library Preparation
• Sequencing
• NGS Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

By Application

• Oncology
  • Diagnostics and Screening
    • Oncology Screening
      • Sporadic Cancer
      • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
  • Research Studies
• Clinical Investigation
  • Infectious Diseases
  • Inherited Diseases
  • Idiopathic Diseases
  • Non-Communicable/Other Diseases
• ReProduct & Serviceive Health
  • NIPT
    • Aneuploidy
    • Microdeletions
  • PGT
    • Newborn Genetic Screening
    • Single Gene Analysis
• HLA Typing/Immune System Monitoring
• Metagenomics
• Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

By End User

• Academic Research
• Clinical Research, Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

The growth of the Next Generation Sequencing (NGS) market is driven by several key factors that collectively contribute to its expanding influence in genomics, healthcare, and research. Here are some of the prominent growth drivers:

1. Advancements in Precision Medicine:

NGS technologies play a crucial role in advancing precision medicine by enabling comprehensive genomic profiling.

The ability to analyze an individual’s genetic makeup facilitates personalized treatment plans based on their unique genetic characteristics.

2. Technological Innovations and Cost Reduction:

Ongoing innovations in NGS platforms, such as improvements in sequencing speed, accuracy, and cost-effectiveness, drive increased adoption.

Continuous efforts to reduce the cost per genome sequenced make NGS more accessible to a wider range of applications.

3. Expanding Diagnostic Applications:

NGS is becoming an integral tool in diagnostics, particularly in identifying genetic markers associated with various diseases.

The technology aids in early detection, prognosis, and treatment decision-making in areas like oncology, rare diseases, and infectious diseases.

4. Research and Drug Discovery:

NGS facilitates high-throughput sequencing, allowing researchers to generate vast amounts of genomic data for comprehensive studies.

The technology accelerates the pace of drug discovery by providing insights into genetic variations and underlying molecular mechanisms.

5. Rising Demand for Biomarker Discovery:

Increasing interest in identifying biomarkers for disease diagnosis, prognosis, and treatment response fuels the demand for NGS.

Biomarker discovery is crucial in developing targeted therapies and improving patient outcomes.

6. Applications in Agriculture and Livestock Genomics:

NGS is applied in agriculture for crop improvement and in livestock genomics for breeding programs.

The technology contributes to enhanced agricultural productivity, sustainability, and the development of disease-resistant crops.

7. Collaborations and Partnerships:

Collaborative initiatives between NGS technology providers, research institutions, and pharmaceutical companies accelerate research and development.

Partnerships foster a collaborative ecosystem, promoting the exchange of knowledge and resources for further innovation.

8. Increasing Demand for Genomic Data in Research:

The growing importance of genomics in various research fields, including biology, ecology, and anthropology, drives the demand for NGS technologies.

Researchers across disciplines leverage NGS to explore genetic diversity and understand complex biological systems.

9. Rising Adoption in Clinical Settings:

Increased adoption of NGS in clinical laboratories for routine diagnostics and disease monitoring contributes to market growth.

NGS technologies are becoming essential tools in clinical genomics, offering insights into hereditary disorders and informing patient care.

The synergy of these drivers positions the Next Generation Sequencing market as a transformative force in the realms of healthcare, research, and beyond, with continuous advancements expected to further broaden its applications and impact.

Table of Content

Chapter 1 Introduction       

Chapter 2 Research Methodology

Chapter 3 Next Generation Sequencing Market Dynamics

Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Next Generation Sequencing Market Segmentation, By Product

Chapter 9 Next Generation Sequencing Market Segmentation, By Technology

Chapter 10 Next Generation Sequencing Market Segmentation, By Workflow

Chapter 11 Next Generation Sequencing Market Segmentation, By Application

Chapter 12 Next Generation Sequencing Market Segmentation, By End User

Chapter 13 Regional Analysis

Chapter 14 Company profile

Chapter 15 Competitive Landscape

Chapter 16 Use Case and Best Practices

Chapter 17 Conclusion

Buy Next Generation Sequencing Market report: https://www.snsinsider.com/checkout/3720

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/